1. Home
  2. FAX vs PRME Comparison

FAX vs PRME Comparison

Compare FAX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAX
  • PRME
  • Stock Information
  • Founded
  • FAX 1986
  • PRME 2019
  • Country
  • FAX United States
  • PRME United States
  • Employees
  • FAX N/A
  • PRME N/A
  • Industry
  • FAX Investment Managers
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • FAX Finance
  • PRME Health Care
  • Exchange
  • FAX Nasdaq
  • PRME Nasdaq
  • Market Cap
  • FAX 632.9M
  • PRME 601.1M
  • IPO Year
  • FAX N/A
  • PRME 2022
  • Fundamental
  • Price
  • FAX $15.36
  • PRME $3.73
  • Analyst Decision
  • FAX
  • PRME Buy
  • Analyst Count
  • FAX 0
  • PRME 6
  • Target Price
  • FAX N/A
  • PRME $9.31
  • AVG Volume (30 Days)
  • FAX 833.6K
  • PRME 4.0M
  • Earning Date
  • FAX 01-01-0001
  • PRME 11-07-2025
  • Dividend Yield
  • FAX 12.09%
  • PRME N/A
  • EPS Growth
  • FAX N/A
  • PRME N/A
  • EPS
  • FAX N/A
  • PRME N/A
  • Revenue
  • FAX N/A
  • PRME $5,977,000.00
  • Revenue This Year
  • FAX N/A
  • PRME $179.58
  • Revenue Next Year
  • FAX N/A
  • PRME N/A
  • P/E Ratio
  • FAX N/A
  • PRME N/A
  • Revenue Growth
  • FAX N/A
  • PRME 647.13
  • 52 Week Low
  • FAX $2.33
  • PRME $1.11
  • 52 Week High
  • FAX $2.84
  • PRME $6.94
  • Technical
  • Relative Strength Index (RSI)
  • FAX 50.18
  • PRME 42.74
  • Support Level
  • FAX $14.83
  • PRME $3.57
  • Resistance Level
  • FAX $15.55
  • PRME $3.84
  • Average True Range (ATR)
  • FAX 0.21
  • PRME 0.38
  • MACD
  • FAX 0.02
  • PRME 0.04
  • Stochastic Oscillator
  • FAX 79.17
  • PRME 59.04

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: